`
`On March 26, 2009, Genentech, Inc. became a whollyowned member of the
`Roche Group. In connection with the privatization, public shareholders
`received $95.00 per share for their shares and Genentech's common stock
`(symbol: DNA) ceased trading on the New York Stock Exchange.
`
`Genentech Historical Prices
`
`NYSE: GNE, 1988 June 15, 1999 (182K/PDF)
`NYSE: DNA, July 20, 1999 March 26, 2009 (169K/PDF)
`
`Share tendering
`
`Questions regarding Genentech shares not tendered in the privatization
`transaction should be directed to BNY Mellon Shareowner Services by phone:
`+1 8662239154 from within the United States, Canada or Puerto Rico (toll free)
`+1 2016806579 from outside the United States
`
`Phones are open 9am to 6pm New York time, Monday through Friday, except for
`bank holidays.
`
`Transmittal materials
`
`By Mail:
`BNY Mellon Shareowner Services
`Attn: Corporate Action Dept.
`PO Box 358300
`Pittsburgh, PA 152528300
`
`IMMUNOGEN 2202, pg. 1
`Phigenix v. Immunogen
`IPR2014-00676
`
`
`
`By Overnight Courier or By Hand:
`
`BNY Mellon Shareowner Services
`Attn: Corporate Action Dept., 27th Floor
`480 Washington Boulevard
`Jersey City, NJ 07310
`
`More information
`Roche Investor Relations North America
`Information for U.S. Investors
`
`IMMUNOGEN 2202, pg. 2
`Phigenix v. Immunogen
`IPR2014-00676